
Ocugen to Showcase Gene Therapy Advances at Upcoming Ophthalmology Conferences
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) will highlight its pioneering modifier gene therapy platform at two major industry events in May 2025. The company will present its clinical advancements …
Ocugen to Showcase Gene Therapy Advances at Upcoming Ophthalmology Conferences Read More